GH Research PLC (GHRS)
NASDAQ: GHRS · Real-Time Price · USD
15.98
+0.05 (0.31%)
At close: Mar 9, 2026, 4:00 PM EDT
15.99
+0.01 (0.05%)
After-hours: Mar 9, 2026, 5:40 PM EDT
GH Research Market Cap
GH Research has a market cap or net worth of $991.23 million as of March 9, 2026. Its market cap has increased by 14.15% in one year.
Market Cap
991.23M
Enterprise Value
684.67M
1-Year Change
14.15%
Ranking
Category
Stock Price
$15.98
Market Cap Chart
Since the IPO on June 25, 2021, GH Research's market cap has increased from $808.33M to $991.23M, an increase of 22.63%. That is a compound annual growth rate of 4.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 988.13M | 25.43% |
| Dec 31, 2025 | 787.77M | 116.30% |
| Dec 31, 2024 | 364.20M | 20.71% |
| Dec 29, 2023 | 301.72M | -40.33% |
| Dec 30, 2022 | 505.64M | -58.34% |
| Dec 31, 2021 | 1.21B | 50.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AbCellera Biologics | 1.07B |
| Inhibrx Biosciences | 1.05B |
| Geron | 1.04B |
| SELLAS Life Sciences Group | 1.01B |
| Aktis Oncology | 1.00B |
| Compass Therapeutics | 976.08M |
| UroGen Pharma | 969.26M |
| Xeris Biopharma Holdings | 965.62M |